Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monobenzyl ether of hydroquinone for depigmentation in vitiligo
PACTR201808699550182Phase 4Completed
- Sponsor
- Cairo University
- Start
- Nov 2016
- Countries
- 1
01
Overview
Phase 4, open-label trial in Vitiligo (2 arms), sponsored by Cairo University. Primary endpoints: Efficacy comparison between 20% and 40% monobenzyl ether of hydroquinone, Tolerability comparison between 20% and 40% monobenzyl ether of hydroquinone and 1 more. Started Nov 2016; status: completed.
02
Conditions
Vitiligo
Beyond the preview
Go deeper on PACTR201808699550182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201808699550182.